New Vaccines in the Pipeline: Norovirus, Lyme Disease, and Combination COVID-19–Flu | IDWeek 2024

Dozens of presentations at IDWeek 2024 focused on currently available immunizations, such as those for COVID-19, respiratory syncytial virus, and flu. In this slideshow, learn more about 3 new vaccines that are currently in development.

READ MORE: Infectious Disease Resource Center

References

1. Messier MD, Wagner L, Hochreiter R, et al. 6-valent, OspA-based VLA15 Lyme disease vaccine candidate against Lyme Borreliosis in a healthy pediatric and adult study population: A phase 2 study update. Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-599.

2. Norovirus. National Foundation for Infectious Diseases. Reviewed July 2023. Accessed October 16, 2024. https://www.nfid.org/infectious-disease/norovirus/

3. About norovirus. CDC. Accessed October 16, 2024. https://www.cdc.gov/norovirus/about/index.html

4. Groom HC, Slaughter MT, Donald JL, et al. Attitudes toward a potential norovirus vaccine among patients with medically-attended acute gastroenteritis in the US. Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-598.

5. Moderna announces first participant dosed in pivotal phase 3 trial of investigational mRNA norovirus vaccine, mRNA-1403. News release. Moderna. September 30, 2024. Accessed October 16, 2024. https://investors.modernatx.com/news/news-details/2024/Moderna-Announces-First-Participant-Dosed-in-Pivotal-Phase-3-Trial-of-Investigational-mRNA-Norovirus-Vaccine-mRNA-1403/default.aspx

6. Shinde V, Neal S, Plested JS, et al. Immunogenicity and tolerability of the Novavax nanoparticle influenza vaccine (NIV) and COVID-influenza combination vaccine (CIC). Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-607.